Tobin Juvenal
Corporate Officer/Principal bei CASTLE BIOSCIENCES, INC.
Vermögen: 982 504 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Derek Maetzold | M | 62 | 17 Jahre | |
| Daniel Bradbury | M | 62 | 12 Jahre | |
| Kimberlee Caple | F | 62 | 3 Jahre | |
| Camilla Zuckero | F | - | 5 Jahre | |
| Miles Harrison | M | 59 | 4 Jahre | |
| Robert W. Cook | M | 52 | 13 Jahre | |
| Ellen Goldberg | F | 50 | 3 Jahre | |
| Kristen Oelschlager | F | 56 | 16 Jahre | |
| Mara Aspinall | F | 61 | 9 Jahre | |
| Tiffany Olson | F | 64 | 3 Jahre | |
| G. Cole | M | 68 | 6 Jahre | |
| Alice Bahner Izzo | F | - | 11 Jahre | |
| Franklin Stokes | M | 54 | 7 Jahre | |
| John C. Cheneval | M | - | 3 Jahre | |
| Matthew Goldberg | M | - | 4 Jahre | |
| Noreen Manning | F | - | - | |
| John Abbott | M | - | 10 Jahre | |
| Keli Greenberg | F | - | 4 Jahre | |
| Chris Otte | M | - | - | |
| Kevin Doman | M | - | 2 Jahre | |
| Johnson Clare | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 Jahre |
| David Kabakoff | M | 76 | - | |
| Paul S. Manierre | M | 70 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 Jahre |
| Bonnie Anderson | F | 66 | 5 Jahre | |
| Joseph Cook | M | 53 | 3 Jahre | |
| Patrick Hall | M | - | - | |
| Bernhard E. Spiess | M | 64 | 5 Jahre | |
| Frank Charles Carlucci | M | 91 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| James L. Dunn | M | 62 | 2 Jahre | |
| William Ringo | M | 78 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 Jahre |
| Garheng Kong | M | 49 | 3 Jahre | |
| Carl Sterritt | M | 55 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| Timothy Decker | M | - | - | |
| Federico A. Monzon | M | 56 | 5 Jahre | |
| Elizabeth Ann Fagan | M | 74 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 2 Jahre |
| Acosta Greg | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 37 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tobin Juvenal
- Persönliches Netzwerk
